Crawford Investment Counsel Inc Abbott Laboratories Transaction History

Crawford Investment Counsel Inc

  • $5.7 Billion
  • Q3 2024

A detailed history of Crawford Investment Counsel Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 31,065 shares of ABT stock, worth $3.64 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
31,065
Previous 29,947 3.73%
Holding current value
$3.64 Million
Previous $3.11 Million 13.82%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$100.07 - $118.13 $111,878 - $132,069
1,118 Added 3.73%
31,065 $3.54 Million
Q2 2024

Aug 14, 2024
SELL
$100.73 - $112.44 $92,470 - $103,219
-918 Reduced 2.97%
29,947 $3.11 Million
Q1 2024

May 15, 2024
SELL
$109.52 - $120.96 $226,158 - $249,782
-2,065 Reduced 6.27%
30,865 $3.51 Million
Q4 2023

Feb 14, 2024
BUY
$90.19 - $110.4 $836,061 - $1.02 Million
9,270 Added 39.18%
32,930 $3.62 Million
Q3 2023

Nov 14, 2023
SELL
$95.53 - $114.62 $82,633 - $99,146
-865 Reduced 3.53%
23,660 $2.29 Million
Q2 2023

Aug 14, 2023
SELL
$100.78 - $112.29 $28,016 - $31,216
-278 Reduced 1.12%
24,525 $2.67 Million
Q1 2023

May 15, 2023
BUY
$96.86 - $114.01 $14,335 - $16,873
148 Added 0.6%
24,803 $2.51 Million
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $54,374 - $63,789
-572 Reduced 2.27%
24,655 $2.71 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $7,547 - $8,738
78 Added 0.31%
25,227 $2.44 Million
Q2 2022

Aug 15, 2022
SELL
$102.07 - $123.37 $917,405 - $1.11 Million
-8,988 Reduced 26.33%
25,149 $2.73 Million
Q1 2022

May 16, 2022
SELL
$114.02 - $139.04 $43,213 - $52,696
-379 Reduced 1.1%
34,137 $4.04 Million
Q4 2021

Feb 07, 2022
SELL
$115.53 - $141.46 $177,569 - $217,424
-1,537 Reduced 4.26%
34,516 $4.86 Million
Q3 2021

Nov 15, 2021
BUY
$116.66 - $129.06 $43,164 - $47,752
370 Added 1.04%
36,053 $4.26 Million
Q2 2021

Aug 16, 2021
BUY
$105.79 - $124.53 $24,754 - $29,140
234 Added 0.66%
35,683 $4.14 Million
Q1 2021

May 14, 2021
SELL
$108.84 - $128.23 $16,543 - $19,490
-152 Reduced 0.43%
35,449 $4.25 Million
Q4 2020

Feb 01, 2021
SELL
$105.0 - $114.42 $52,815 - $57,553
-503 Reduced 1.39%
35,601 $3.9 Million
Q3 2020

Oct 29, 2020
BUY
$91.64 - $111.29 $20,069 - $24,372
219 Added 0.61%
36,104 $3.93 Million
Q2 2020

Aug 13, 2020
SELL
$76.57 - $98.0 $43,568 - $55,762
-569 Reduced 1.56%
35,885 $3.28 Million
Q1 2020

May 15, 2020
SELL
$62.82 - $91.86 $112,824 - $164,980
-1,796 Reduced 4.7%
36,454 $2.88 Million
Q4 2019

Feb 14, 2020
SELL
$78.51 - $87.4 $28,342 - $31,551
-361 Reduced 0.93%
38,250 $3.32 Million
Q3 2019

Nov 12, 2019
BUY
$81.84 - $88.74 $635,978 - $689,598
7,771 Added 25.2%
38,611 $3.23 Million
Q2 2019

Aug 12, 2019
SELL
$72.88 - $85.0 $72,661 - $84,745
-997 Reduced 3.13%
30,840 $2.59 Million
Q1 2019

May 09, 2019
BUY
$66.22 - $80.06 $83,635 - $101,115
1,263 Added 4.13%
31,837 $2.55 Million
Q4 2018

Feb 14, 2019
BUY
$65.56 - $74.27 $154,983 - $175,574
2,364 Added 8.38%
30,574 $2.21 Million
Q3 2018

Nov 09, 2018
BUY
$60.81 - $73.36 $71,938 - $86,784
1,183 Added 4.38%
28,210 $2.07 Million
Q2 2018

Aug 14, 2018
BUY
$57.57 - $63.54 $35,060 - $38,695
609 Added 2.31%
27,027 $1.65 Million
Q1 2018

May 15, 2018
SELL
$56.27 - $63.62 $72,588 - $82,069
-1,290 Reduced 4.66%
26,418 $1.58 Million
Q4 2017

Feb 13, 2018
BUY
$53.68 - $57.47 $61,732 - $66,090
1,150 Added 4.33%
27,708 $1.58 Million
Q3 2017

Nov 14, 2017
BUY
$48.06 - $53.64 $1.28 Million - $1.42 Million
26,558
26,558 $1.42 Million

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Crawford Investment Counsel Inc Portfolio

Follow Crawford Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email